Please login to the form below

David Chantry appointed as Head of Quality & Compliance (UK and Ireland) for Ashfield Commercial and Clinical

David has been successful in a number of roles across various healthcare environments prior to joining the company, and has taken over this important leadership role to spearhead the development and implementation of the quality and compliance initiatives as they relate to the business and regulatory requirements in the UK and Ireland.

David, who will be responsible for delivery of quality and compliance initiatives as well as inputting to overall strategy and development, commented: “I’m delighted to be part of a great team and working in such a dynamic and pivotal part of the business. Ensuring that high standards of care and service delivery are maintained, and that Ashfield is compliant with our regulatory obligations is a vital area within the industry. This is crucial as our clients, patients and other stakeholders seek assurances that we can provide them with a safe and effective service, whilst continually seeking to improve what we do.

I’m looking forward to continuing our partnership with our current clients and to developing new business with future prospects. "Talking about how his experience in the sector will help shape this role, David said: “I started work in the healthcare sector over 25 years ago as a Nursing Assistant, before training and qualifying to diploma level as a Registered Nurse. 
My area of work and speciality was Critical Care. I then went on to complete a bachelor’s degree in Health Related Studies before leaving the National Health Service in 2002. Since then I have been lucky to experience many different roles, including sales, marketing and business development within the medical devices field. Since 2010, I have held a number of key roles at a Senior Nursing level which have focussed on quality, compliance and governance of clinical service delivery. Throughout my career, since qualifying as a nurse, I have maintained my nursing registration and will continue to do so.”

Discussing the future of the Ashfield Quality and Compliance Department, David explained: “We have a well-established and committed team within the department, whose focus is on developing and improving the standards and effectiveness of the services that we provide in order to improve the lives of our patients. We are also dedicated to supporting our colleagues and partnering with our clients to achieve exactly the same mission. Clients are always seeking to assure patients, healthcare providers and professionals that the services that they invest in and deliver are safe and effective, and that they are continually improving.

The Quality and Compliance Department will continue to support and evolve in accordance with regulatory, client and patient requirements, which means we are constantly evaluating the way we work, as a team and as an organisation.”

If you would like to understand more about Ashfield and what we do, please visit our website:

20th October 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

‘Delivering healthcare events with certainty and impact’
Ashfield Meetings & Events launches new website
The Ashfield Solution - Accelerate product uptake and maximize ROI
A pioneering multichannel optimization model powered by advanced analytics with the ability to flex resources based on real time results.
Patient Engagement and Experience Conference, 16-17 May
Ashfield and S3 Connected Health, Silver Sponsors at the 3rd Annual Patient Engagement and Experience Conference in Amsterdam on 16-17 May, will be speaking on how digitally enhanced Patient Support Programmes can extend the continuity and relevance of care into patients’ everyday lives.
Ashfield will be exhibiting at ISMPP US
On 30 April - 2 May 2018, Ashfield Healthcare Communications will be exhibiting at the 14th Annual Meeting of ISMPP at the Gaylord National Resort & Convention Center, National Harbor, MD.
Putting the patient first
You’ve invested millions in the development of your new drug or therapy and have successfully completed clinical trials - now you are ready to launch. Data has been collected, efficacy is understood and side effects are recorded. But an important question remains: is your target patient population prepared?
Ashfield joins the eyeforpharma webinar: The PSP Masterclass
Nagore Fernandez, Ashfield’s Head of Patient Services for EUCAN and Anna Baker, a Consultant in Health Psychology working closely with Ashfield, are joining an eyeforpharma panel debate: 'How Health Psychology drives winning Patient Support Programmes'. The webinar will take place Thursday 26th April at 9am New York, 2pm UK and 3pm Paris time.